Compound GLP-1s, Anesthesia Prices And More In Court
By Gianna Ferrarin · March 31, 2026, 7:52 PM EDT
A Fifth Circuit panel heard arguments from compounding pharmacies alleging the U.S. Food and Drug Administration skipped procedural steps when removing their ability to create compound versions of certain GLP-1 weight...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login